Guangzhou Hexin Instrument Hits Day Low of CNY 65.50 Amid Price Pressure

Guangzhou Hexin Instrument Co., Ltd. has experienced significant volatility today, with the stock hitting an intraday low of CNY 65.50. The company, operating in the Pharmaceuticals & Biotechnology sector, has seen its stock price decline by 11.8% on March 17, 2026. This drop is part of a broader trend, as the stock has lost 17.97% over the past week and a staggering 53.19% over the last month. In terms of performance metrics, Guangzhou Hexin has reported a year-to-date decline of 34.5%, contrasting sharply with the China Shanghai Composite, which has gained 2.04% during the same period. The company's financial health appears concerning, with operating losses and a negative net profit reported for the last two consecutive quarters. The debt-to-equity ratio stands at 0.61, indicating a relatively high level of debt compared to equity. Overall, the stock's performance reflects ongoing challenges, with a weak long-term growth outlook and declining sales figures. Investors may want to monitor these developments closely as the company navigates its current financial landscape.